Back to Search
Start Over
Efficacy and Safety of Fidanacogene Elaparvovec in Adults with Moderately Severe or Severe Hemophilia B: Results from the Phase 3 BENEGENE-2 Gene Therapy Trial.
- Source :
- Hämostaseologie; 2024 Supplement 1, Vol. 44, pS81-S82, 2p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 07209355
- Volume :
- 44
- Database :
- Complementary Index
- Journal :
- Hämostaseologie
- Publication Type :
- Academic Journal
- Accession number :
- 175707205
- Full Text :
- https://doi.org/10.1055/s-0044-1779185